Skip to main content
Erschienen in: Critical Care 5/2009

01.10.2009 | Review

Year in review 2008: Critical Care - sepsis

verfasst von: Steven M Opal, Steven P LaRosa

Erschienen in: Critical Care | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

The present report highlights the most important papers appearing in Critical Care and other major journals about severe sepsis, the systemic inflammatory response and multiorgan dysfunction over the past year. A number of these clinical and laboratory studies will have a considerable impact on the sepsis research agenda for years to come. The steroid controversy, the debate over tight glycemic control, the colloid versus crystalloid issue, the value of selective decontamination of the digestive tract, the enlarging role of biomarkers, the value of genomics and rapid diagnostic techniques have all been prominently featured in recent publications. Basic research into novel predictive assays, genetic polymorphisms, and new molecular methods to risk-stratify and to determine treatment options for sepsis have occupied much of the Critical Care publications relating to sepsis pathophysiology in 2008. We will attempt to briefly summarize what we consider to be the most significant contributions to the sepsis literature over the last year, and their likely ramifications in the future, for critical care clinicians, clinical investigators and basic researchers alike.
Literatur
1.
Zurück zum Zitat Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini J, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini J, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41CrossRefPubMed
2.
Zurück zum Zitat El Solh AA, Akinnusi ME, Alsawalha L, Pineda L: Outcome of septic shock in older adults after implementation of the sepsis 'bundle'. J Am Geriatr Soc 2008, 56: 272-278. 10.1111/j.1532-5415.2007.01529.xCrossRefPubMed El Solh AA, Akinnusi ME, Alsawalha L, Pineda L: Outcome of septic shock in older adults after implementation of the sepsis 'bundle'. J Am Geriatr Soc 2008, 56: 272-278. 10.1111/j.1532-5415.2007.01529.xCrossRefPubMed
3.
Zurück zum Zitat Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV: Improvement in process of care and outcome after a multicenter severe sepsis education program in Spain. JAMA 2008, 299: 2294-2303. 10.1001/jama.299.19.2294CrossRefPubMed Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Diaz G, Garnacho-Montero J, Ibanez J, Palencia E, Quintana M, de la Torre-Prados MV: Improvement in process of care and outcome after a multicenter severe sepsis education program in Spain. JAMA 2008, 299: 2294-2303. 10.1001/jama.299.19.2294CrossRefPubMed
4.
Zurück zum Zitat Carlet J, Cohen J, Calandra T, Opal SM, Masur H: Sepsis: time to reconsider the concept. Crit Care Med 2008, 36: 964-966. 10.1097/CCM.0B013E318165B886CrossRefPubMed Carlet J, Cohen J, Calandra T, Opal SM, Masur H: Sepsis: time to reconsider the concept. Crit Care Med 2008, 36: 964-966. 10.1097/CCM.0B013E318165B886CrossRefPubMed
5.
Zurück zum Zitat Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Rheinhart K, Cutbertson BH, Payen D, Briegel J, Corticus Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358: 111-124. 10.1056/NEJMoa071366CrossRefPubMed Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Rheinhart K, Cutbertson BH, Payen D, Briegel J, Corticus Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358: 111-124. 10.1056/NEJMoa071366CrossRefPubMed
6.
Zurück zum Zitat Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288: 862-871. 10.1001/jama.288.7.862CrossRefPubMed Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288: 862-871. 10.1001/jama.288.7.862CrossRefPubMed
7.
Zurück zum Zitat Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grend S, Olthoff D, Jaschiniski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716CrossRefPubMed Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grend S, Olthoff D, Jaschiniski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716CrossRefPubMed
8.
Zurück zum Zitat The NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360: 1283-1297. 10.1056/NEJMoa0810625CrossRef The NICE-SUGAR Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360: 1283-1297. 10.1056/NEJMoa0810625CrossRef
9.
Zurück zum Zitat deSmet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, Werf TS, Hoeven JG, Pickkers P, Bogaers Hofman D, Meer NJM, Bernards AT, Kuijper EJ, Joore JCA, Leverstein-van Hall MA, Bindels AJGH, Jansz AR, Wesselink RMJ, de Jongh BM, Dennesen PJW, van Asselt GJ, te Velde LF, Frenay IHME, Kaasjager K, Bosch FH, van Iterson M, Thijsen SFT, Kluge GH, Pauw W, de Vries JW, Kaan JA, et al.: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360: 20-31. 10.1056/NEJMoa0800394CrossRef deSmet AMGA, Kluytmans JAJW, Cooper BS, Mascini EM, Benus RFJ, Werf TS, Hoeven JG, Pickkers P, Bogaers Hofman D, Meer NJM, Bernards AT, Kuijper EJ, Joore JCA, Leverstein-van Hall MA, Bindels AJGH, Jansz AR, Wesselink RMJ, de Jongh BM, Dennesen PJW, van Asselt GJ, te Velde LF, Frenay IHME, Kaasjager K, Bosch FH, van Iterson M, Thijsen SFT, Kluge GH, Pauw W, de Vries JW, Kaan JA, et al.: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360: 20-31. 10.1056/NEJMoa0800394CrossRef
10.
Zurück zum Zitat Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB: Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12: R6. 10.1186/cc6770PubMedCentralCrossRefPubMed Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Hong SB: Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12: R6. 10.1186/cc6770PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Abidi K, Khoudri I, Belayachi J, Mandani N, Zekraoui A, Zeggwagh AA, Abouqal R: Eosinopenia is a reliable marker of sepsis on admission to the medical intensive care units. Crit Care 2008, 12: R59. 10.1186/cc6883PubMedCentralCrossRefPubMed Abidi K, Khoudri I, Belayachi J, Mandani N, Zekraoui A, Zeggwagh AA, Abouqal R: Eosinopenia is a reliable marker of sepsis on admission to the medical intensive care units. Crit Care 2008, 12: R59. 10.1186/cc6883PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Wang H, Cheng B, Chen Q, Wu S, Lv S, Xie G, Jin Y, Fang X: Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008, 12: R106. 10.1186/cc6988PubMedCentralCrossRefPubMed Wang H, Cheng B, Chen Q, Wu S, Lv S, Xie G, Jin Y, Fang X: Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008, 12: R106. 10.1186/cc6988PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR: Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care 2008, 12: R12. 10.1186/cc6785PubMedCentralCrossRefPubMed Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR: Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care 2008, 12: R12. 10.1186/cc6785PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira , Paulo JZ: Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12: R11. 10.1186/cc6780PubMedCentralCrossRefPubMed Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira , Paulo JZ: Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008, 12: R11. 10.1186/cc6780PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Zhou M, Jacob A, Ho N, Miksa M, Wu R, Maitra SR, Wang P: Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release. Crit Care 2008, 12: R100. 10.1186/cc6977PubMedCentralCrossRefPubMed Zhou M, Jacob A, Ho N, Miksa M, Wu R, Maitra SR, Wang P: Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release. Crit Care 2008, 12: R100. 10.1186/cc6977PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Weber S, Schewe JC, Lehmann LE, Muller S, Book M, Klaschik S, Hoeft A, Stuber F: Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008, 12: R128. 10.1186/cc7088PubMedCentralCrossRefPubMed Weber S, Schewe JC, Lehmann LE, Muller S, Book M, Klaschik S, Hoeft A, Stuber F: Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 2008, 12: R128. 10.1186/cc7088PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Trachsel S, Deby-Dupont G, Maurenbrecher E, Nys M, Lamy M, Hedenstierna G: Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care 2008, 12: R131. 10.1186/cc7099PubMedCentralCrossRefPubMed Trachsel S, Deby-Dupont G, Maurenbrecher E, Nys M, Lamy M, Hedenstierna G: Association between inflammatory mediators and response to inhaled nitric oxide in a model of endotoxin-induced lung injury. Crit Care 2008, 12: R131. 10.1186/cc7099PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Martins PS, Brunialti MKC, Martos LSW, Machado FR, Assuncao MS, Blecher S, Salomao R: Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 2008, 12: R25. 10.1186/cc6801PubMedCentralCrossRefPubMed Martins PS, Brunialti MKC, Martos LSW, Machado FR, Assuncao MS, Blecher S, Salomao R: Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 2008, 12: R25. 10.1186/cc6801PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA: Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008, 12: R103. 10.1186/cc6983PubMedCentralCrossRefPubMed Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA: Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008, 12: R103. 10.1186/cc6983PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350: 451-458. 10.1056/NEJMoa031544CrossRefPubMed Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350: 451-458. 10.1056/NEJMoa031544CrossRefPubMed
21.
Zurück zum Zitat Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordigon P, Fabbri LM: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004, 24: 247-250. 10.1183/09031936.04.00014204CrossRefPubMed Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordigon P, Fabbri LM: Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004, 24: 247-250. 10.1183/09031936.04.00014204CrossRefPubMed
22.
Zurück zum Zitat Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM: Soluble triggering receptor expressed on myeloid cells-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132: 58-63. 10.1378/chest.06-2731CrossRefPubMed Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM: Soluble triggering receptor expressed on myeloid cells-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132: 58-63. 10.1378/chest.06-2731CrossRefPubMed
23.
Zurück zum Zitat Anand NJ, Zuick S, Klesney-Tait J, Kollef MH: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135: 641-647. 10.1378/chest.08-1829CrossRefPubMed Anand NJ, Zuick S, Klesney-Tait J, Kollef MH: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135: 641-647. 10.1378/chest.08-1829CrossRefPubMed
24.
Zurück zum Zitat Gil H, Magy N, Mauny F, Dupond JL: Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2006, 27: 431-435.CrossRef Gil H, Magy N, Mauny F, Dupond JL: Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2006, 27: 431-435.CrossRef
25.
Zurück zum Zitat Bass DA, Gonwa TA, Szejda P, Cousart S, DeChatelet LR, McCall CE: Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute infl ammation. J Clin Invest 1980, 65: 1265-1271. 10.1172/JCI109789PubMedCentralCrossRefPubMed Bass DA, Gonwa TA, Szejda P, Cousart S, DeChatelet LR, McCall CE: Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute infl ammation. J Clin Invest 1980, 65: 1265-1271. 10.1172/JCI109789PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Tang BMP, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7: 210-217. 10.1016/S1473-3099(07)70052-XCrossRefPubMed Tang BMP, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7: 210-217. 10.1016/S1473-3099(07)70052-XCrossRefPubMed
27.
Zurück zum Zitat Becker K, Snider R, Nylen ES: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36: 941-952. 10.1097/CCM.0B013E318165BABBCrossRefPubMed Becker K, Snider R, Nylen ES: Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36: 941-952. 10.1097/CCM.0B013E318165BABBCrossRefPubMed
28.
Zurück zum Zitat Lee WM, Galbraith RM: The extracellular actin-scavenging system and actin toxicity. N Engl J Med 1992, 326: 1335-1341.CrossRefPubMed Lee WM, Galbraith RM: The extracellular actin-scavenging system and actin toxicity. N Engl J Med 1992, 326: 1335-1341.CrossRefPubMed
29.
Zurück zum Zitat Osborn TM, Dahlgren C, Hartwig JH, Stossel TP: Modifications of the cellular responses to lypophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007, 292: C1323-C1330. 10.1152/ajpcell.00510.2006CrossRefPubMed Osborn TM, Dahlgren C, Hartwig JH, Stossel TP: Modifications of the cellular responses to lypophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007, 292: C1323-C1330. 10.1152/ajpcell.00510.2006CrossRefPubMed
30.
Zurück zum Zitat Suhler E, Lin W, Yin HL, Lee WM: Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock and myonecrosis. Crit Care Med 1997, 25: 594-598. 10.1097/00003246-199704000-00007CrossRefPubMed Suhler E, Lin W, Yin HL, Lee WM: Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock and myonecrosis. Crit Care Med 1997, 25: 594-598. 10.1097/00003246-199704000-00007CrossRefPubMed
31.
Zurück zum Zitat Lee PS, Waxman AB, Cotich KL, Shung SW, Perrella MA, Stossel TP: Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007, 35: 849-855. 10.1097/01.CCM.0000253815.26311.24CrossRefPubMed Lee PS, Waxman AB, Cotich KL, Shung SW, Perrella MA, Stossel TP: Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007, 35: 849-855. 10.1097/01.CCM.0000253815.26311.24CrossRefPubMed
32.
Zurück zum Zitat Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB: Plasma gelsolin depletion and circulating actin in sepsis - a pilot study. PLoS One 2008, 3: e3712. 10.1371/journal.pone.0003712PubMedCentralCrossRefPubMed Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB: Plasma gelsolin depletion and circulating actin in sepsis - a pilot study. PLoS One 2008, 3: e3712. 10.1371/journal.pone.0003712PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Fiedler U, Augustin HG: Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006, 27: 552-558. 10.1016/j.it.2006.10.004CrossRefPubMed Fiedler U, Augustin HG: Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006, 27: 552-558. 10.1016/j.it.2006.10.004CrossRefPubMed
34.
Zurück zum Zitat Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12: R147. 10.1186/cc7130PubMedCentralCrossRefPubMed Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12: R147. 10.1186/cc7130PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Parikh SM, Mammoto T, Schultz A, Yuan H-T, Christiani D, Karumanchi SA, Sukhatme VP: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3: e46. 10.1371/journal.pmed.0030046PubMedCentralCrossRefPubMed Parikh SM, Mammoto T, Schultz A, Yuan H-T, Christiani D, Karumanchi SA, Sukhatme VP: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3: e46. 10.1371/journal.pmed.0030046PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Witzenbichler B, Westermann D, Kneuppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111: 97-105. 10.1161/01.CIR.0000151287.08202.8ECrossRefPubMed Witzenbichler B, Westermann D, Kneuppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111: 97-105. 10.1161/01.CIR.0000151287.08202.8ECrossRefPubMed
37.
Zurück zum Zitat Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestuich GD, Macarenhas M, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medshitov R, Nobel PW: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11: 1173-1179. 10.1038/nm1315CrossRefPubMed Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestuich GD, Macarenhas M, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medshitov R, Nobel PW: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11: 1173-1179. 10.1038/nm1315CrossRefPubMed
38.
Zurück zum Zitat Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, Syrkina O, Huang PM, Garg HG, Hales CA, Quinn DA: High-molecular-weight hyaluronan - a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care 2008, 12: R102. 10.1186/cc6982PubMedCentralCrossRefPubMed Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, Syrkina O, Huang PM, Garg HG, Hales CA, Quinn DA: High-molecular-weight hyaluronan - a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care 2008, 12: R102. 10.1186/cc6982PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Meulema DG: Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis 1992, 22: 58-65. Meulema DG: Orgaran (Org 10172): its pharmacological profile in experimental models. Haemostasis 1992, 22: 58-65.
40.
Zurück zum Zitat Bartlett AH, Hayashida K, Park PW: Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol Cells 2007, 24: 153-166.PubMed Bartlett AH, Hayashida K, Park PW: Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol Cells 2007, 24: 153-166.PubMed
41.
Zurück zum Zitat Iba T, Miyasho T: Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats. Crit Care 2008, 12: R86. 10.1186/cc6943PubMedCentralCrossRefPubMed Iba T, Miyasho T: Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats. Crit Care 2008, 12: R86. 10.1186/cc6943PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T: Danaparoid sodium inhibits inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 2008, 12: R43. 10.1186/cc6851PubMedCentralCrossRefPubMed Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T: Danaparoid sodium inhibits inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 2008, 12: R43. 10.1186/cc6851PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Muñoz A: Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE Study). Crit Care Med 2009, 37: 1185-1196. 10.1097/CCM.0b013e31819c06bcCrossRefPubMed Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Muñoz A: Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE Study). Crit Care Med 2009, 37: 1185-1196. 10.1097/CCM.0b013e31819c06bcCrossRefPubMed
44.
Zurück zum Zitat Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A: Leukocyte apoptosis and its significance in sepsis and septic shock. J Leukoc Biol 2005, 78: 325-337. 10.1189/jlb.0105017CrossRefPubMed Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A: Leukocyte apoptosis and its significance in sepsis and septic shock. J Leukoc Biol 2005, 78: 325-337. 10.1189/jlb.0105017CrossRefPubMed
45.
Zurück zum Zitat Hostmann A, Jasse K, Schulze-Tanzil G, Robinson Y, Oberholzer A, Ertel W, Tschoeke SK: Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mci-1 proteins. Crit Care 2008, 12: R8. 10.1186/cc6772PubMedCentralCrossRefPubMed Hostmann A, Jasse K, Schulze-Tanzil G, Robinson Y, Oberholzer A, Ertel W, Tschoeke SK: Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mci-1 proteins. Crit Care 2008, 12: R8. 10.1186/cc6772PubMedCentralCrossRefPubMed
46.
Zurück zum Zitat Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB-1: guiding immunity for within. Trends Immunol 2005, 26: 381-387. 10.1016/j.it.2005.04.009CrossRefPubMed Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P: HMGB-1: guiding immunity for within. Trends Immunol 2005, 26: 381-387. 10.1016/j.it.2005.04.009CrossRefPubMed
47.
Zurück zum Zitat Kornblit B, Munthe-Fog L, Madsen HO, Strom J, Vindelov L, Garred P: Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 2008, 12: R83. 10.1186/cc6935PubMedCentralCrossRefPubMed Kornblit B, Munthe-Fog L, Madsen HO, Strom J, Vindelov L, Garred P: Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 2008, 12: R83. 10.1186/cc6935PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Flores C, del Mar Pino-Yanes M, Villar J: A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008, 12: R130. 10.1186/cc7098PubMedCentralCrossRefPubMed Flores C, del Mar Pino-Yanes M, Villar J: A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008, 12: R130. 10.1186/cc7098PubMedCentralCrossRefPubMed
Metadaten
Titel
Year in review 2008: Critical Care - sepsis
verfasst von
Steven M Opal
Steven P LaRosa
Publikationsdatum
01.10.2009
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 5/2009
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc7945

Weitere Artikel der Ausgabe 5/2009

Critical Care 5/2009 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.